Preview

National Journal glaucoma

Advanced search

The effect of preoperative topical anti-inflammatory treatment on anterior segment and trabeculectomy outcomes assessed by venous oxygen saturation

Abstract

PURPOSE: To study the effect of local preoperative therapy with steroid and non-steroid anti-inflammatory drugs (NSAIDs) (on the level of the oxygen saturation in anterior segment tissues and prolonging the hypotensive effect of trabeculectomy. METHODS: 80 patients with primary open-angle glaucoma were randomized into 4 groups of 20 people according to the study drug: Nepafenac, Dexasone, their non-fixed combination and the control group with no preoperative therapy. All patients underwent trabeculectomy. The patients administered 1 drop of study drug b.i.d. for 2 weeks before the operation and were examined each day for the first week, on weeks 1, 2 and 4, and on months 3, 6 and 12. Oxygen saturation (SO2) was measured in supralimbal and sublimbal deep conjunctival veins before and after 2 weeks of anti-inflammatory therapy. Main outcome measure was the incidence of postoperative surgical or medical interventions (needling, needling revision, hypotensive therapy). RESULTS: In combined anti-inflammatory treatment group, SO2 increased by 5.2% (from 53.6 to 56.4%), in steroid treatment group - by 4.7% (from 52.7 to 55.2%), in nonsteroidal treatment group - by 2.6% (from 53.4 to 54.8%). In controls, no significant changes in SO2 were observed. 50% of patients in the control group needed postoperative needling, 35% in the NSAIDs, 30% - in the steroid drug group and 20% - in the combined therapy group. 10% of the control group and 5% of the NSAIDs required a needling-revision in the postoperative period. Patients from the steroid and combined therapy groups had no need of a needling procedure. 50% of patients in the control group, 35% in the NSAIDs group, 25% in the steroid drug group and 20% in the combined therapy group required further hypotensive therapy. Complete surgery success in the course of the first year amounted to 50% in patients in the control group, 65% in the NSAIDs group, 75% of the steroid drug group and 80% in the combined therapy group. Qualified success during the first year after surgery totaled 100% in all the groups. CONCLUSION: Pre-op topical anti-inflammatory treatment significantly increased venous oxygen saturation in anterior segment tissues which correlated with 1-year rate of absolute success of trabeculectomy as compared with controls. Local preoperative administration of anti-inflammatory drugs helped increase the complete surgery success throughout a year after trabeculectomy as compared to the control group. The best hypotensive effect was noted in the combined therapy group (80%), then - in the steroid and non-steroid monotherapy groups (75% and 65%).

About the Authors

S. Yu. Petrov
The Scientific Research Institute of Eye Diseases
Russian Federation


A. A. Antonov
The Scientific Research Institute of Eye Diseases
Russian Federation


A. S. Makarova
The Scientific Research Institute of Eye Diseases
Russian Federation


T. A. Savel’Eva
Institute of General Physics of RAS; National Research Nuclear University «Moscow Engineering Physics Institute»
Russian Federation


A. V. Ryabova
Institute of General Physics of RAS; National Research Nuclear University «Moscow Engineering Physics Institute»
Russian Federation


V. B. Loshchenov
Institute of General Physics of RAS; National Research Nuclear University «Moscow Engineering Physics Institute»
Russian Federation


References

1. European Glaucoma Society: Terminology and Guidelines for Glaucoma. 3rd ed.: Savona, Italy: Editrice Dogma; 2008.

2. Chang L., Crowston J.G., Cordeiro M.F., Akbar A.N., Khaw P.T. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol 2000; 45(1):49-68.

3. Baudouin C., Pisella P.J., Fillacier K., Goldschild M. et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999; 106(3):556-563. doi: 10.1016/S0161-6420(99)90116-1.

4. Baudouin C., Liang H., Hamard P., Riancho L. et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008; 115(1):109-115. doi: 10.1016/j.ophtha.2007.01.036.

5. Baudouin C., Hamard P., Liang H., Creuzot-Garcher C., Bensous-san L., Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 2004; 111(12):2186-2192. doi: 10.1016/j.ophtha.2004.06.023.

6. Baudouin C., Labbe A., Liang H., Pauly A., Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Progress in Retinal and Eye Research 2010; 29(4):312-334. doi: 10.1016/j.preteyeres.2010.03.001.

7. Broadway D.C., Grierson I., O’Brien C., Hitchings R.A. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994; 112(11):1446-1454.

8. Broadway D.C., Grierson I., O’Brien C., Hitchings R.A. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 1994; 112(11):1437-1445.

9. Lama P.J., Fechtner R.D. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48(3):314-346.

10. Artifoni E., Campana G. [Comparative study of the structural changes of the bulbar conjunctiva in aged subjects with and without glaucoma]. Annali di Ottalmologia e Clinica Oculistica 1966; 92(12):1342-1348.

11. Малаханова Н.А. Изменения конъюнктивы при глаукоме. Вестник офтальмологии 1966; 79(3):70-73.

12. Федоров С.Н., Ронкина Т.И., Васин В.И. Клинико-морфологическое сравнение состояния кровеносных сосудов в дренажной зоне склеры и радужной оболочки при различных стадиях открытоугольной глаукомы. Офтальмологический журнал 1981; 36(1):12-16

13. Краснов М.М., Зиангирова Г.Г., Шмырева В.Ф., Акберова С.И. Клинико-морфологические характеристики микроциркуляции конъюнктивы и радужки при открытоугольной глаукоме. Вестник офтальмологии 1993; 109(5):7-10

14. Шмырева В.Ф., Петров С.Ю., Антонов А.А., Стратонников А.А., Савельева Т.А., Шевчик С.А., Рябова А.В., Урываев Ю.В. Исследование метаболизма тканей переднего отрезка глаза по уровню оксигенации гемоглобина в венозном русле при первичной открытоугольной глаукоме. Глаукома 2008; 3:3-10

15. Baudouin C., Nordmann J.P., Denis P., Creuzot-Garcher C., Allaire C., Trinquand C. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs. Graefe’s Arch Clin Exper Ophthalmol = Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie 2002; 240(11):929-935. doi: 10.1007/s00417-002-0581-9.

16. Nguyen K.D., Lee D.A. Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast. Invest Ophthalmol Vis Sci 1992; 33(9):2693-2701.

17. Breusegem C., Spielberg L., Van Ginderdeuren R., Vandewalle E. et al. Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology 2010; 117(7):1324-1330. doi: 10.1016/j.ophtha.2009.11.038.

18. Shaarawry T.M. et al. Guidelines on design and reporting of glaucoma surgical trials. Kugler Publications, 2009.

19. Глаукома. Национальное руководство. Под ред. Е.А. Егорова. М.: ГЭОТАР-Медиа, 2013. 824 с.


Review

For citations:


Petrov S.Yu., Antonov A.A., Makarova A.S., Savel’Eva T.A., Ryabova A.V., Loshchenov V.B. The effect of preoperative topical anti-inflammatory treatment on anterior segment and trabeculectomy outcomes assessed by venous oxygen saturation. National Journal glaucoma. 2016;15(3):43-51. (In Russ.)

Views: 666


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-4104 (Print)
ISSN 2311-6862 (Online)